AffiliationFaculty of Health Sciences, University of Ottawa, Ottawa, Canada; Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, Canada; Médecins Sans Frontiers, Geneva, Switzerland; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, South Africa
MetadataShow full item record
JournalThe Lancet Infectious Diseases
AbstractWe are entering a new phase in the strategic use of antiretroviral drugs. In addition to dramatically reducing HIV/AIDS-related morbidity and mortality, these drugs have recently shown an important effect in reducing HIV incidence and transmission.
- Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on "Managed problem solving for antiretroviral therapy adherence".
- Authors: Bangsberg DR, Haberer JE
- Issue date: 2013 Feb 25
- The effectiveness of social resource intervention to promote adherence to HIV medication in a multidisciplinary care setting in Kenya.
- Authors: Kamau TM, Olsen VG, Zipp GP, Clark M
- Issue date: 2012 Dec
- Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz.
- Authors: Cooper V, Moyle GJ, Fisher M, Reilly G, Ewan J, Liu HC, Horne R, SWEET (Simplification With Easier Emtricitabine Tenofovir) group, UK.
- Issue date: 2011 Jun
- Reply: To PMID 23358784.
- Authors: Gross R, Bellamy SL, Strom BL
- Issue date: 2013 Aug 12
- Long-term trends in adherence to antiretroviral therapy from start of HAART.
- Authors: Cambiano V, Lampe FC, Rodger AJ, Smith CJ, Geretti AM, Lodwick RK, Puradiredja DI, Johnson M, Swaden L, Phillips AN
- Issue date: 2010 May 15